$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How much does Pfizer's lorlatinib cost in the United States
2025-10-19 11:44:20
Check Details
Amivantamab for the treatment of metastatic NSCLC with EGFR exon 20 insertion_ Kanghule
2025-10-19 11:44:20
Check Details
Is the price of Pfizer's lorlatinib expensive in the United States
2025-10-19 11:44:20
Check Details
Instructions for use of Pfizer's Lorlatinib
2025-10-19 11:44:20
Check Details
Applicable groups of Pfizer's lorlatinib in the United States
2025-10-19 11:44:20
Check Details
FDA approves sotorasib for the treatment of KRAS G12C locally advanced or metastatic NSCLC_Canghule
2025-10-19 11:44:20
Check Details
How effective is Jisandai?
2025-10-19 11:44:20
Check Details
How effective is cabozantinib?
2025-10-19 11:44:20
Check Details
Alectinib price
2025-10-19 11:44:20
Check Details
What diseases does aletinib treat?
2025-10-19 11:44:20
Check Details
How much does a box of Aletinib cost?
2025-10-19 11:44:20
Check Details
How many tablets of alectinib should be taken a day?
2025-10-19 11:44:20
Check Details
1
2
...
9774
9775
9776
9777
9778
9779
9780
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
2
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
3
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
4
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
5
A Precision FGFR Inhibitor for Cholangiocarcinoma
6
A Revolutionary Targeted Therapy for Hematological Malignancies
7
A New Option for Advanced Renal Cell Carcinoma Treatment
8
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
9
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
10
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
11
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
12
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications